Improvement of erythrocyte deformability by cholesterol-lowering therapy with pravastatin in hypercholesterolemic patients

This publication has 26 references indexed in Scilit:

• Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia.
  Circulation, 1994
• Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension.
  Journal of Clinical Investigation, 1993
• Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease.
  Circulation, 1993
• Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions.
  Journal of Clinical Investigation, 1993
• Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)
  The Lancet, 1992
• Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B
  New England Journal of Medicine, 1990
• Can lifestyle changes reverse coronary heart disease?: The Lifestyle Heart Trial
  Published by Elsevier ,1990
• Endothelium-dependent vascular relaxation is abnormal in the coronary microcirculation of atherosclerotic primates.
  Circulation, 1990
• The Pathogenesis of Atherosclerosis — An Update
  New England Journal of Medicine, 1986
• INCREASED BLOOD VISCOSITY AND FIBRINOLYTIC INHIBITOR IN TYPE II HYPERLIPOPROTEINAEMIA
  The Lancet, 1982